Juno Pharma plans strategic review and explores possible sale

MELBOURNE: Rich List debutant Dennis Bastas, the chairman and major shareholder of Juno Pharmaceuticals, has

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In